ResMed (RMD) CFO Brett Sandercock Sells 1,000 Shares

What Happened
Brett Sandercock, Chief Financial Officer of ResMed Inc. (RMD), sold 1,000 shares on February 2, 2026, at $257.03 per share for total proceeds of $257,030. The sale is reported as an open-market disposition (S) and was carried out under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-02-02; Price: $257.03 per share; Shares sold: 1,000; Proceeds: $257,030.
• Sale executed under a Rule 10b5-1 plan adopted February 19, 2025 (pre-arranged trading plan).
• Filing date: 2026-02-03 — reported promptly (filed the next day, within Form 4 timing requirements).
• Shares owned following the transaction: not specified in the provided filing details.
• Transaction code: S = Sale (open-market/private sale).

Context
Sales made under 10b5-1 plans are typically pre-scheduled and can be routine portfolio-management actions rather than contemporaneous signals about the company. For retail investors, purchases often carry more informational weight than routine, pre-arranged sales.